List of Tables
Table 1. Global Newborn Screening for SMA and SCID Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Instruments
Table 3. Key Players of Kits
Table 4. Key Players of Software
Table 5. Global Newborn Screening for SMA and SCID Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Newborn Screening for SMA and SCID Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Newborn Screening for SMA and SCID Market Size by Region (US$ Million), 2021–2026
Table 8. Global Newborn Screening for SMA and SCID Market Share by Region (2021–2026)
Table 9. Global Newborn Screening for SMA and SCID Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Newborn Screening for SMA and SCID Market Share by Region (2027–2032)
Table 11. Newborn Screening for SMA and SCID Market Trends
Table 12. Newborn Screening for SMA and SCID Market Drivers
Table 13. Newborn Screening for SMA and SCID Market Challenges
Table 14. Newborn Screening for SMA and SCID Market Restraints
Table 15. Global Newborn Screening for SMA and SCID Revenue by Players (US$ Million), 2021–2026
Table 16. Global Newborn Screening for SMA and SCID Market Share by Players (2021–2026)
Table 17. Global Top Newborn Screening for SMA and SCID Players by Tier (Tier 1, Tier 2, and Tier 3), based on Newborn Screening for SMA and SCID Revenue, 2025
Table 18. Ranking of Global Top Newborn Screening for SMA and SCID Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Newborn Screening for SMA and SCID Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Newborn Screening for SMA and SCID, Headquarters and Area Served
Table 21. Global Key Players of Newborn Screening for SMA and SCID, Products and Applications
Table 22. Global Key Players of Newborn Screening for SMA and SCID, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Newborn Screening for SMA and SCID Market Size by Type (US$ Million), 2021–2026
Table 25. Global Newborn Screening for SMA and SCID Revenue Market Share by Type (2021–2026)
Table 26. Global Newborn Screening for SMA and SCID Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Newborn Screening for SMA and SCID Revenue Market Share by Type (2027–2032)
Table 28. Global Newborn Screening for SMA and SCID Market Size by Application (US$ Million), 2021–2026
Table 29. Global Newborn Screening for SMA and SCID Revenue Market Share by Application (2021–2026)
Table 30. Global Newborn Screening for SMA and SCID Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Newborn Screening for SMA and SCID Revenue Market Share by Application (2027–2032)
Table 32. North America Newborn Screening for SMA and SCID Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Newborn Screening for SMA and SCID Market Size by Country (US$ Million), 2021–2026
Table 34. North America Newborn Screening for SMA and SCID Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Newborn Screening for SMA and SCID Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Newborn Screening for SMA and SCID Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Newborn Screening for SMA and SCID Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Newborn Screening for SMA and SCID Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Newborn Screening for SMA and SCID Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Newborn Screening for SMA and SCID Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Newborn Screening for SMA and SCID Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Newborn Screening for SMA and SCID Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Newborn Screening for SMA and SCID Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Newborn Screening for SMA and SCID Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Newborn Screening for SMA and SCID Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Newborn Screening for SMA and SCID Market Size by Country (US$ Million), 2027–2032
Table 47. Perkinelmer Company Details
Table 48. Perkinelmer Business Overview
Table 49. Perkinelmer Newborn Screening for SMA and SCID Product
Table 50. Perkinelmer Revenue in Newborn Screening for SMA and SCID Business (US$ Million), 2021–2026
Table 51. Perkinelmer Recent Development
Table 52. Thermo Fisher Company Details
Table 53. Thermo Fisher Business Overview
Table 54. Thermo Fisher Newborn Screening for SMA and SCID Product
Table 55. Thermo Fisher Revenue in Newborn Screening for SMA and SCID Business (US$ Million), 2021–2026
Table 56. Thermo Fisher Recent Development
Table 57. ImmunoIVD Company Details
Table 58. ImmunoIVD Business Overview
Table 59. ImmunoIVD Newborn Screening for SMA and SCID Product
Table 60. ImmunoIVD Revenue in Newborn Screening for SMA and SCID Business (US$ Million), 2021–2026
Table 61. ImmunoIVD Recent Development
Table 62. Labsystems Diagnostics Company Details
Table 63. Labsystems Diagnostics Business Overview
Table 64. Labsystems Diagnostics Newborn Screening for SMA and SCID Product
Table 65. Labsystems Diagnostics Revenue in Newborn Screening for SMA and SCID Business (US$ Million), 2021–2026
Table 66. Labsystems Diagnostics Recent Development
Table 67. Research Programs/Design for This Report
Table 68. Key Data Information from Secondary Sources
Table 69. Key Data Information from Primary Sources
Table 70. Authors List of This Report
List of Figures
Figure 1. Newborn Screening for SMA and SCID Picture
Figure 2. Global Newborn Screening for SMA and SCID Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Newborn Screening for SMA and SCID Market Share by Type: 2025 vs 2032
Figure 4. Instruments Features
Figure 5. Kits Features
Figure 6. Software Features
Figure 7. Global Newborn Screening for SMA and SCID Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Newborn Screening for SMA and SCID Market Share by Application: 2025 vs 2032
Figure 9. SCID Screening Case Studies
Figure 10. SMA Screening Case Studies
Figure 11. Newborn Screening for SMA and SCID Report Years Considered
Figure 12. Global Newborn Screening for SMA and SCID Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global Newborn Screening for SMA and SCID Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Newborn Screening for SMA and SCID Market Share by Region: 2025 vs 2032
Figure 15. Global Newborn Screening for SMA and SCID Market Share by Players in 2025
Figure 16. Global Newborn Screening for SMA and SCID Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Newborn Screening for SMA and SCID Revenue in 2025
Figure 18. North America Newborn Screening for SMA and SCID Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America Newborn Screening for SMA and SCID Market Share by Country (2021–2032)
Figure 20. United States Newborn Screening for SMA and SCID Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada Newborn Screening for SMA and SCID Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Newborn Screening for SMA and SCID Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Newborn Screening for SMA and SCID Market Share by Country (2021–2032)
Figure 24. Germany Newborn Screening for SMA and SCID Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France Newborn Screening for SMA and SCID Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. Newborn Screening for SMA and SCID Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy Newborn Screening for SMA and SCID Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia Newborn Screening for SMA and SCID Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland Newborn Screening for SMA and SCID Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Newborn Screening for SMA and SCID Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Newborn Screening for SMA and SCID Market Share by Region (2021–2032)
Figure 32. China Newborn Screening for SMA and SCID Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan Newborn Screening for SMA and SCID Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea Newborn Screening for SMA and SCID Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia Newborn Screening for SMA and SCID Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India Newborn Screening for SMA and SCID Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand Newborn Screening for SMA and SCID Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Newborn Screening for SMA and SCID Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Newborn Screening for SMA and SCID Market Share by Country (2021–2032)
Figure 40. Mexico Newborn Screening for SMA and SCID Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil Newborn Screening for SMA and SCID Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Newborn Screening for SMA and SCID Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Newborn Screening for SMA and SCID Market Share by Country (2021–2032)
Figure 44. Israel Newborn Screening for SMA and SCID Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia Newborn Screening for SMA and SCID Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE Newborn Screening for SMA and SCID Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Perkinelmer Revenue Growth Rate in Newborn Screening for SMA and SCID Business (2021–2026)
Figure 48. Thermo Fisher Revenue Growth Rate in Newborn Screening for SMA and SCID Business (2021–2026)
Figure 49. ImmunoIVD Revenue Growth Rate in Newborn Screening for SMA and SCID Business (2021–2026)
Figure 50. Labsystems Diagnostics Revenue Growth Rate in Newborn Screening for SMA and SCID Business (2021–2026)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
